NHSBT uses cookies which are essential for the site to work. We also use non-essential cookies to help us improve our services, any data collected is anonymised. By continuing to use this website you agree to our use of cookies. Read more about our cookies
Hi there, we see you're using OS, why not try our app?
Download
Skip to main content
1

7 April: Our adjusted service provision over the April bank holiday.

We have sufficient stocks to supply to your needs

Service provision; red cell and platelet stock levels

Component portfolio and prices

Ordering plasma from 6 April 2020

Ordering plasma

Changes to neonatal platelet component specification from 14 January 2020

From this date, neonatal components will be manufactured to a revised specification, which will improve their quality for transfusion. The specification includes clinical implications.

The component portfolio is being updated to include the specification. 

Revised specification

Portfolio 

Portfolio of blood components and guidance 

This provides details of therapeutic blood components supplied to hospitals, including constituents, and information on:

  • specifications
  • identification barcodes
  • quality standards and monitoring
  • storage and handling
  • clinical indications and contraindications
  • specialist requirements
  • dosage, administration, recognition of adverse effects
  • material safety data sheet

Prices

Price list 

Availability of non stock and special components

Availability of non stock and special components including components required for urgent requests. 

SaBTO’s recommendations on vCJD risk reduction measures

NHSBT communication issued 9 September 2019 regarding the Department for Health and Social Care's (DHSC) notification of the ministerial decision to accept SaBTO’s recommendations on vCJD risk reduction measures in England, Wales and Scotland for plasma and platelet recipients born on or after 1 January 1996.